化学抗原受体-T细胞疗法降低了远程转移,并抑制了小鼠手术后局部复发

Dan Li1, Lin Jiang1, Weilin Zhou1

  • 1Department of Biotherapy, The State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Human gene therapy
|November 2, 2023
PubMed
概括

化学抗原受体 (CAR) -T细胞疗法在手术后有效清除循环瘤细胞 (CTC),减少转移并防止瘤复发. 这种辅助疗法有望改善癌症治疗结果.